BioStem Technologies, Inc. (OTCMKTS:BSEM – Get Free Report)’s share price traded up 7.1% during mid-day trading on Friday . The company traded as high as $11.00 and last traded at $10.82. 43,477 shares traded hands during trading, a decline of 30% from the average session volume of 61,929 shares. The stock had previously closed at $10.10.
BioStem Technologies Price Performance
The firm has a market cap of $180.39 million, a PE ratio of 15.91 and a beta of -0.39. The stock’s fifty day moving average price is $13.98 and its 200-day moving average price is $13.85.
BioStem Technologies Company Profile
BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.
See Also
- Five stocks we like better than BioStem Technologies
- 3 Warren Buffett Stocks to Buy Now
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- 3 ETFs to Ride the VIX Surge During Market Volatility
- Overbought Stocks Explained: Should You Trade Them?
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for BioStem Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioStem Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
